AstraZeneca, European Commission Settle Dispute Over Vaccine Supply
September 03 2021 - 4:47AM
Dow Jones News
By Jaime Llinares Taboada
AstraZeneca PLC said Friday that it has reached a settlement
agreement with the European Commission over its Covid-19 vaccine,
ending the litigation between the pharmaceutical company and the
European Union's executive body.
AstraZeneca said it has committed to delivering 60 million doses
by the end of the third quarter, 75 million by the end of the
fourth quarter, and 65 million by the end of the first quarter of
2022.
Shares at 0814 GMT were up 0.5% at 8,658 pence.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com;
@JaimeLlinaresT
(END) Dow Jones Newswires
September 03, 2021 04:32 ET (08:32 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2024 to May 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From May 2023 to May 2024
